Femme et Homme
- | Pays :
- United States
- New Zealand
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to determine the maximum tolerated dose (MTD) of CEP-18770 in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.
Critère d'inclusion
- Multiple myeloma